(Q34789122)

4 August 2017

1 reference

title

G-CSF as prophylaxis of febrile neutropenia in SCLC. (English)

1 reference

4 August 2017

Jared R Adams

1

1 reference

4 August 2017

Gary H Lyman

2

1 reference

4 August 2017

Benjamin Djubegovic

3

1 reference

4 August 2017

Joe Feinglass

4

1 reference

4 August 2017

Charles L Bennett

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Expert Opinion on Pharmacotherapy

4 August 2017

published in

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1273-1281

1 reference

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.9.1273

Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.9.1273

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.9.1273

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.9.1273

10.1517/14656566.3.9.1273

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference